A potential advance against RAS-driven cancers—researchers find certain inhibitors can short-circuit mutation signals
Each year, more than 3 million people are diagnosed with cancers driven by mutations in three RAS-family genes: KRAS, NRAS, and HRAS. RAS-family mutations are associated with numerous types of cancer.
Oct 31, 2024
0
2
